Recent research from NYU Langone Health has revealed that a combination of 27 bacterial and fungal species in the oral microbiome is associated with a 3.5 times increased risk of pancreatic cancer. This groundbreaking study, led by Dr. Yixuan Meng, analyzed saliva samples from 122,000 individuals, tracking their health outcomes over several years to identify those who developed pancreatic cancer.
The findings suggest that oral microbiota could serve as potential biomarkers for pancreatic cancer risk, marking a significant advancement in understanding this lethal disease, which has a dismal five-year survival rate of just 13%. The study highlights the need for improved scientific knowledge regarding the causes of pancreatic cancer, as known risk factors account for less than 30% of cases.
As the oral microbiome gains attention for its role in overall health, this research underscores the potential for oral health interventions to serve as preventive measures against pancreatic cancer. The ability to profile oral microbial populations may enable oncologists to identify individuals at high risk, paving the way for personalized screening and preventive strategies. Further investigation is needed to establish direct causal relationships and explore the role of oral viruses in cancer risk.
Use the database as your supply chain compass →
